Aesthetic plastic surgery · 2026
Immediate Implant-Based Breast Reconstruction: Analysis of 787 Cases and Definition of Our Decision-Making Algorithm.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taraschi Federico, Barone Adesi Liliana, Ratti Nicole, Visconti Giuseppe, Ricci Luca, Scardina Lorenzo, Franceschini Gianluca, Salgarello Marzia
Аннотация
BACKGROUND: Immediate implant-based breast reconstruction (IBBR) following nipple-sparing (NSM) or skin-sparing mastectomy (SSM) increasingly requires individualized technique selection. Choosing among prepectoral direct-to-implant (DTI), submuscular DTI, and two-stage expander reconstruction remains complex. This study analyses outcomes from a large single-centre cohort to define a pragmatic, evidence-based decision-making algorithm.
METHODS: A retrospective monocentric review included all consecutive IBBR procedures performed between 2018 and 2024. Patients were allocated to three groups: prepectoral DTI (n = 601), submuscular DTI (n = 142), and two-stage expander reconstruction (n = 44). Demographic, oncologic, and surgical variables were collected. Major complications were evaluated using unadjusted analyses and inverse-probability-of-treatment weighting. A dedicated subgroup analysis was performed for patients receiving postmastectomy radiotherapy (PMRT).
RESULTS: A total of 1,093 breasts were reconstructed. Weighted analysis showed similar overall major-complication rates for prepectoral and submuscular DTI (7.3% vs 8.4%, p = 0.278), while expanders demonstrated the lowest adjusted risk (0.7%). Within the PMRT subgroup, prepectoral DTI did not show increased infection, dehiscence, or seroma compared with the other techniques; infection was significantly lower than in submuscular DTI (2.7% vs 14.3%, p = 0.020). Capsular contracture was markedly less frequent in prepectoral DTI and remained significantly reduced after multivariable adjustment (OR 1 [reference]; OR 9.03 for submuscular DTI; OR 3.25 for expanders).
CONCLUSIONS: Our resulting algorithm offers a structured, patient-specific approach to optimise outcomes in immediate implant-based breast reconstruction.
LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
METHODS: A retrospective monocentric review included all consecutive IBBR procedures performed between 2018 and 2024. Patients were allocated to three groups: prepectoral DTI (n = 601), submuscular DTI (n = 142), and two-stage expander reconstruction (n = 44). Demographic, oncologic, and surgical variables were collected. Major complications were evaluated using unadjusted analyses and inverse-probability-of-treatment weighting. A dedicated subgroup analysis was performed for patients receiving postmastectomy radiotherapy (PMRT).
RESULTS: A total of 1,093 breasts were reconstructed. Weighted analysis showed similar overall major-complication rates for prepectoral and submuscular DTI (7.3% vs 8.4%, p = 0.278), while expanders demonstrated the lowest adjusted risk (0.7%). Within the PMRT subgroup, prepectoral DTI did not show increased infection, dehiscence, or seroma compared with the other techniques; infection was significantly lower than in submuscular DTI (2.7% vs 14.3%, p = 0.020). Capsular contracture was markedly less frequent in prepectoral DTI and remained significantly reduced after multivariable adjustment (OR 1 [reference]; OR 9.03 for submuscular DTI; OR 3.25 for expanders).
CONCLUSIONS: Our resulting algorithm offers a structured, patient-specific approach to optimise outcomes in immediate implant-based breast reconstruction.
LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .